168 related articles for article (PubMed ID: 35480387)
61. Comparison of Linear vs. Cyclic RGD Pentapeptide Interactions with Integrin α
Li N; Qiu S; Fang Y; Wu J; Li Q
Biology (Basel); 2021 Jul; 10(7):. PubMed ID: 34356543
[TBL] [Abstract][Full Text] [Related]
62. Site-specific inhibition of integrin alpha v beta 3-vitronectin association by a ser-asp-val sequence through an Arg-Gly-Asp-binding site of the integrin.
Choi Y; Kim E; Lee Y; Han MH; Kang IC
Proteomics; 2010 Jan; 10(1):72-80. PubMed ID: 19882657
[TBL] [Abstract][Full Text] [Related]
63. Designed synthetic analogs of the α-helical peptide temporin-La with improved antitumor efficacies via charge modification and incorporation of the integrin αvβ3 homing domain.
Diao Y; Han W; Zhao H; Zhu S; Liu X; Feng X; Gu J; Yao C; Liu S; Sun C; Pan F
J Pept Sci; 2012 Jul; 18(7):476-86. PubMed ID: 22641352
[TBL] [Abstract][Full Text] [Related]
64. RGDX
Yamada Y; Onda T; Hagiuda A; Kan R; Matsunuma M; Hamada K; Kikkawa Y; Nomizu M
FASEB J; 2022 Jul; 36(7):e22389. PubMed ID: 35657599
[TBL] [Abstract][Full Text] [Related]
65. Binding and uptake of novel RGD micelles to the αvβ3 integrin receptor for targeted drug delivery.
Raj A; Saraf P; Javali NM; Li X; Jasti B
J Drug Target; 2014 Jul; 22(6):518-27. PubMed ID: 24611965
[TBL] [Abstract][Full Text] [Related]
66. Preclinical evaluation of a dual sstr2 and integrin α
Liu B; Zhang Z; Wang H; Yao S
Bioorg Med Chem; 2019 Nov; 27(21):115094. PubMed ID: 31540828
[TBL] [Abstract][Full Text] [Related]
67. A new cyclic RGD peptide dimer for integrin αvβ3 imaging.
Ma H; Hao P; Zhang L; Ma C; Yan P; Wang RF; Zhang CL
Eur Rev Med Pharmacol Sci; 2016; 20(4):613-9. PubMed ID: 26957261
[TBL] [Abstract][Full Text] [Related]
68. 68Ga- and 111In-labelled DOTA-RGD peptides for imaging of alphavbeta3 integrin expression.
Decristoforo C; Hernandez Gonzalez I; Carlsen J; Rupprich M; Huisman M; Virgolini I; Wester HJ; Haubner R
Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1507-15. PubMed ID: 18369617
[TBL] [Abstract][Full Text] [Related]
69. In vitro and in vivo evaluation of a novel 99mTc(CO)3-pyrazolyl conjugate of cyclo-(Arg-Gly-Asp-d-Tyr-Lys).
Alves S; Correia JD; Gano L; Rold TL; Prasanphanich A; Haubner R; Rupprich M; Alberto R; Decristoforo C; Santos I; Smith CJ
Bioconjug Chem; 2007; 18(2):530-7. PubMed ID: 17373771
[TBL] [Abstract][Full Text] [Related]
70. Single cell tracking assay reveals an opposite effect of selective small non-peptidic α5β1 or αvβ3/β5 integrin antagonists in U87MG glioma cells.
Ray AM; Schaffner F; Janouskova H; Noulet F; Rognan D; Lelong-Rebel I; Choulier L; Blandin AF; Lehmann M; Martin S; Kapp T; Neubauer S; Rechenmacher F; Kessler H; Dontenwill M
Biochim Biophys Acta; 2014 Sep; 1840(9):2978-87. PubMed ID: 24810979
[TBL] [Abstract][Full Text] [Related]
71. Solid-phase synthesis of a nonpeptide RGD mimetic library: new selective alphavbeta3 integrin antagonists.
Sulyok GA; Gibson C; Goodman SL; Hölzemann G; Wiesner M; Kessler H
J Med Chem; 2001 Jun; 44(12):1938-50. PubMed ID: 11384239
[TBL] [Abstract][Full Text] [Related]
72. Fluorescent RGD-based pro-apoptotic peptide conjugates as mitochondria-targeting probes for enhanced anticancer activities.
Rizvi SFA; Mu S; Wang Y; Li S; Zhang H
Biomed Pharmacother; 2020 Jul; 127():110179. PubMed ID: 32387862
[TBL] [Abstract][Full Text] [Related]
73. Design of integrin α
Lv X; Zhang C; Shuaizhen Q; Yu R; Zheng Y
Biomed Pharmacother; 2020 Aug; 128():110236. PubMed ID: 32447209
[TBL] [Abstract][Full Text] [Related]
74. Distal M domain of cobra ADAM-like metalloproteinase mediates the binding of positively charged cysteine-rich domain to αvβ3 integrin in the suppression of cell migration.
Wu PL; Lin CC; Lin TH; Lee MS; Wu WG
Toxicon; 2016 Aug; 118():1-12. PubMed ID: 27090013
[TBL] [Abstract][Full Text] [Related]
75. Synthesis and Biological Evaluation of RGD⁻Cryptophycin Conjugates for Targeted Drug Delivery.
Borbély A; Figueras E; Martins A; Esposito S; Auciello G; Monteagudo E; Di Marco A; Summa V; Cordella P; Perego R; Kemker I; Frese M; Gallinari P; Steinkühler C; Sewald N
Pharmaceutics; 2019 Apr; 11(4):. PubMed ID: 30939768
[TBL] [Abstract][Full Text] [Related]
76. Corrigendum: RGD Peptidomimetic MMAE-Conjugate Addressing Integrin αVβ3-Expressing Cells with High Targeting Index.
Paulus J; Nachtigall B; Meyer P; Sewald N
Chemistry; 2023 Apr; 29(23):e202300886. PubMed ID: 37021741
[No Abstract] [Full Text] [Related]
77. In vivo therapeutic effects of small molecule-drug conjugates enhanced by Fc grafting.
Zheng Y; Xu R; Chen S; Tai W
Biomaterials; 2022 Nov; 290():121820. PubMed ID: 36194956
[TBL] [Abstract][Full Text] [Related]
78. Synthesis and Evaluation of Small Molecule Drug Conjugates Harnessing Thioester-Linked Maytansinoids.
Lo CF; Chiu TY; Liu YT; Huang LR; Yeh TK; Huang KH; Liu KL; Hsu CY; Fang MY; Huang YC; Hsu TA; Chen CT; Tsou LK
Pharmaceutics; 2022 Jun; 14(7):. PubMed ID: 35890212
[TBL] [Abstract][Full Text] [Related]
79. A click-ready pH-triggered phosphoramidate-based linker for controlled release of monomethyl auristatin E.
Olatunji FP; Herman JW; Kesic BN; Olabode D; Berkman CE
Tetrahedron Lett; 2020 Oct; 61(41):. PubMed ID: 33191958
[TBL] [Abstract][Full Text] [Related]
80. Cell shape characteristics of human skeletal muscle cells as a predictor of myogenic competency: A new paradigm towards precision cell therapy.
Desprez C; Danovi D; Knowles CH; Day RM
J Tissue Eng; 2023; 14():20417314221139794. PubMed ID: 36949843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
